Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9AZE1
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 89 | 93 | PF00656 | 0.706 |
CLV_NRD_NRD_1 | 116 | 118 | PF00675 | 0.547 |
CLV_PCSK_FUR_1 | 117 | 121 | PF00082 | 0.444 |
CLV_PCSK_KEX2_1 | 119 | 121 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 71 | 73 | PF00082 | 0.363 |
CLV_PCSK_PC1ET2_1 | 119 | 121 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 71 | 73 | PF00082 | 0.363 |
CLV_PCSK_SKI1_1 | 105 | 109 | PF00082 | 0.522 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.718 |
LIG_Clathr_ClatBox_1 | 42 | 46 | PF01394 | 0.536 |
LIG_FHA_1 | 154 | 160 | PF00498 | 0.669 |
LIG_FHA_1 | 35 | 41 | PF00498 | 0.590 |
LIG_IRF3_LxIS_1 | 42 | 48 | PF10401 | 0.315 |
LIG_LIR_Gen_1 | 50 | 57 | PF02991 | 0.582 |
LIG_LIR_Nem_3 | 50 | 56 | PF02991 | 0.587 |
LIG_PCNA_yPIPBox_3 | 59 | 68 | PF02747 | 0.470 |
LIG_PDZ_Class_2 | 155 | 160 | PF00595 | 0.738 |
LIG_SH2_PTP2 | 53 | 56 | PF00017 | 0.593 |
LIG_SH2_STAT3 | 17 | 20 | PF00017 | 0.522 |
LIG_SH2_STAT5 | 53 | 56 | PF00017 | 0.533 |
LIG_SH2_STAT5 | 67 | 70 | PF00017 | 0.364 |
LIG_SH3_CIN85_PxpxPR_1 | 148 | 153 | PF14604 | 0.617 |
LIG_SUMO_SIM_anti_2 | 48 | 58 | PF11976 | 0.493 |
LIG_SUMO_SIM_par_1 | 86 | 92 | PF11976 | 0.750 |
LIG_TRAF2_1 | 107 | 110 | PF00917 | 0.588 |
LIG_TRAF2_1 | 76 | 79 | PF00917 | 0.701 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.652 |
MOD_CK2_1 | 45 | 51 | PF00069 | 0.467 |
MOD_CK2_1 | 57 | 63 | PF00069 | 0.440 |
MOD_CK2_1 | 73 | 79 | PF00069 | 0.669 |
MOD_CK2_1 | 83 | 89 | PF00069 | 0.686 |
MOD_GlcNHglycan | 28 | 31 | PF01048 | 0.734 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.506 |
MOD_GSK3_1 | 134 | 141 | PF00069 | 0.657 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.711 |
MOD_N-GLC_1 | 153 | 158 | PF02516 | 0.670 |
MOD_NEK2_1 | 57 | 62 | PF00069 | 0.487 |
MOD_PIKK_1 | 138 | 144 | PF00454 | 0.737 |
MOD_PKA_1 | 71 | 77 | PF00069 | 0.378 |
MOD_PKA_2 | 20 | 26 | PF00069 | 0.625 |
MOD_PKA_2 | 71 | 77 | PF00069 | 0.615 |
MOD_Plk_1 | 153 | 159 | PF00069 | 0.669 |
MOD_Plk_1 | 34 | 40 | PF00069 | 0.480 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.742 |
TRG_DiLeu_BaEn_1 | 109 | 114 | PF01217 | 0.511 |
TRG_DiLeu_BaEn_1 | 52 | 57 | PF01217 | 0.449 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.593 |
TRG_Pf-PMV_PEXEL_1 | 120 | 124 | PF00026 | 0.465 |
TRG_Pf-PMV_PEXEL_1 | 126 | 131 | PF00026 | 0.496 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0NQZ0 | Trypanosomatidae | 35% | 82% |
A0A3R7K6D4 | Trypanosoma rangeli | 35% | 98% |
A0A3S7X104 | Leishmania donovani | 91% | 100% |
A4HG12 | Leishmania braziliensis | 78% | 99% |
A4I331 | Leishmania infantum | 90% | 100% |
C9ZJK4 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 36% | 66% |
E9ACV2 | Leishmania major | 90% | 100% |
V5B8D3 | Trypanosoma cruzi | 37% | 91% |